SCHEMBL3645490

SCHEMBL3645490

NC(=O)CN(C(=O)c1nc(N)sc1-c1ccccc1)C1CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.49
KDM4E B2RXH2 4/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
HSD17B10 Q99714 2/20 0.49
HPGD P15428 1/20 0.49
CYP1A2 P05177 3/20 0.40
MAPT P10636 3/20 0.40
CYP2D6 P10635 2/20 0.40
CYP2C19 P33261 2/20 0.40
PKM P14618 3/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
GAA P10253 2/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
PIN1 Q13526 1/20 0.36
DRD2 P14416 1/20 0.35
DRD3 P35462 1/20 0.35
COPS5 Q92905 1/20 0.35
FBP1 P09467 2/20 0.35
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3643882 0.90 KDM4E (0.39) ALDH1A1KDM4ESMN1; SMN2HSD17B10HPGD
SCHEMBL3641359 0.88 S1PR1 (0.38) ALDH1A1KDM4ESMN1; SMN2HSD17B10HPGD
SCHEMBL3649838 0.87 HCRTR1 (0.46) HCRTR1HCRTR2
SCHEMBL3644734 0.87 HCRTR1 (0.39) ALDH1A1KDM4ESMN1; SMN2HSD17B10HPGD
SCHEMBL3642335 0.87 HCRTR1 (0.44) ALDH1A1KDM4ESMN1; SMN2HSD17B10HPGD
SCHEMBL3645723 0.86 HCRTR1 (0.43) ALDH1A1KDM4ESMN1; SMN2HSD17B10HPGD
SCHEMBL3645494 0.86 ALDH1A1 (0.49) ALDH1A1KDM4ESMN1; SMN2HSD17B10HPGD
SCHEMBL3647390 0.85 FBP1 (0.43) ALDH1A1KDM4ESMN1; SMN2HSD17B10HPGD
SCHEMBL3643655 0.82 ALDH1A1 (0.47) ALDH1A1KDM4ESMN1; SMN2HSD17B10HPGD
SCHEMBL3646179 0.78 HCRTR1 (0.42) HCRTR1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2188282-B1 1,2-DIAMIDO-ETHYLENE DERIVATIVES AS OREXIN ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2013-01-23 EP claimed
EP-2188282-A2 1,2-DIAMIDO-ETHYLENE DERIVATIVES AS OREXIN ANTAGONISTS Actelion Pharmaceuticals Ltd. (CH) 2010-05-26 EP claimed
WO-2009022311-A2 1,2-DIAMIDO-ETHYLENE DERIVATIVES AS OREXIN ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2009-02-19 WO claimed
EP-2188282-B1 1,2-DIAMIDO-ETHYLENE DERIVATIVES AS OREXIN ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2013-01-23 EP disclosed
EP-2188282-A2 1,2-DIAMIDO-ETHYLENE DERIVATIVES AS OREXIN ANTAGONISTS Actelion Pharmaceuticals Ltd. (CH) 2010-05-26 EP disclosed
WO-2009022311-A2 1,2-DIAMIDO-ETHYLENE DERIVATIVES AS OREXIN ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2009-02-19 WO disclosed